BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 20970030)

  • 1. Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers.
    Vissink A; Mitchell JB; Baum BJ; Limesand KH; Jensen SB; Fox PC; Elting LS; Langendijk JA; Coppes RP; Reyland ME
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):983-91. PubMed ID: 20970030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of stem cells in the prevention and treatment of radiation-induced xerostomia in patients with head and neck cancer.
    Nevens D; Nuyts S
    Cancer Med; 2016 Jun; 5(6):1147-53. PubMed ID: 26880659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of salivary hypofunction during and after radiotherapy.
    Shiboski CH; Hodgson TA; Ship JA; Schiødt M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S66.e1-19. PubMed ID: 17379158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current ideas to reduce or salvage radiation damage to salivary glands.
    Vissink A; van Luijk P; Langendijk JA; Coppes RP
    Oral Dis; 2015 Jan; 21(1):e1-10. PubMed ID: 24581290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary Gland Hypofunction and Xerostomia in Head and Neck Radiation Patients.
    Jensen SB; Vissink A; Limesand KH; Reyland ME
    J Natl Cancer Inst Monogr; 2019 Aug; 2019(53):. PubMed ID: 31425600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current status of prevention and management of radiation-induced xerostomia].
    Ma DY; Qiu WL; Zhang CP
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Feb; 45(2):121-3. PubMed ID: 20368009
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathophysiology and management of radiation-induced xerostomia.
    Berk LB; Shivnani AT; Small W
    J Support Oncol; 2005; 3(3):191-200. PubMed ID: 15915820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary gland sparing in the treatment of head and neck cancer.
    Scrimger R
    Expert Rev Anticancer Ther; 2011 Sep; 11(9):1437-48. PubMed ID: 21929317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of radiotherapy-induced salivary hypofunction and consequent xerostomia in patients with oral or head and neck cancer: meta-analysis and literature review.
    Lovelace TL; Fox NF; Sood AJ; Nguyen SA; Day TA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 May; 117(5):595-607. PubMed ID: 24650370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation-induced xerostomia in patients with head and neck cancer: a literature review.
    Dirix P; Nuyts S; Van den Bogaert W
    Cancer; 2006 Dec; 107(11):2525-34. PubMed ID: 17078052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xerostomia management in the head and neck radiation patient.
    Haveman CW
    Tex Dent J; 2004 Jun; 121(6):483-97. PubMed ID: 15354667
    [No Abstract]   [Full Text] [Related]  

  • 12. Questionable validity of the systematic review and meta-analysis by Lovelace et al. on management of radiotherapy-induced salivary hypofunction and xerostomia in patients with oral or head and neck cancer.
    Mercadante V; Lodi G; Porter S; Fedele S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jan; 119(1):120-1. PubMed ID: 25482550
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer.
    Jham BC; Teixeira IV; Aboud CG; Carvalho AL; Coelho Mde M; Freire AR
    Oral Oncol; 2007 Feb; 43(2):137-42. PubMed ID: 16798061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome.
    Rhodus NL; Bereuter J
    J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy-induced salivary dysfunction.
    Ship JA; Hu K
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):29-36. PubMed ID: 15726520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xerostomia prevention after head and neck cancer treatment.
    Seikaly H
    Arch Otolaryngol Head Neck Surg; 2003 Feb; 129(2):250-1. PubMed ID: 12578460
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene transfer-mediated functional restoration for irradiated salivary glands.
    Wang SL; Gao RT
    Chin J Dent Res; 2011; 14(1):7-13. PubMed ID: 21734941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical commentary on prophylactic treatment of radiation-induced xerostomia.
    Chambers MS
    Arch Otolaryngol Head Neck Surg; 2003 Feb; 129(2):251-2. PubMed ID: 12578461
    [No Abstract]   [Full Text] [Related]  

  • 19. Manifestations and treatment of xerostomia and associated oral effects secondary to head and neck radiation therapy.
    Garg AK; Malo M
    J Am Dent Assoc; 1997 Aug; 128(8):1128-33. PubMed ID: 9260423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preemptive pharmacologic intervention in radiation-induced salivary dysfunction.
    Taylor SE; Miller EG
    Proc Soc Exp Biol Med; 1999 May; 221(1):14-26. PubMed ID: 10320627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.